Administration of aminoglycosides to hemodialysis patients immediately before dialysis: A new dosing modality

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2597-2601

  Matsuo, Hidenori ^a   Hayashi, Junichi ^a   Ono, Kumeo ^a   Andoh, Kimiko ^a   Andoh, Yoshitaka ^a   Sano, Yoshiaki ^a   Saruki, Kazuhisa ^a   Tanaka, Junsuke ^b   Yamashita, Mamoru ^b   Nakamura, Kazunori ^c   Kubo, Kazuo ^c  

^a Hidaka Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CELLULOSE ACETATE; ETHYLENE VINYL ALCOHOL COPOLYMER; FOSFOMYCIN; HABEKACIN; POLY(METHYL METHACRYLATE); VANCOMYCIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DIALYSIS MEMBRANE; DOSE RESPONSE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SPUTUM CULTURE;

EID: 0030734122     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2597     Document Type: Article

References (14)

1. Agarwal, R., and R. D. Toto. 1993. Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers. Am. J. Kidney Dis. 22:296-299.
2. Aoki, Y. 1994. Bactericidal activity of arbekacin against methicilin resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn. J. Antibiot. 47:640-646.
3. Begg, E. J., M. L. Barclay, and S. B. Dufful. 1995. A suggested approach to once-daily aminoglycoside dosing. Br. J. Clin. Pharmacol. 39:605-609.
4. Corea, A. L. 1993. The hemodialysis procedure, p. 93. In A. R. Nissenson and R. N. Fine, Dialysis therapy. Hanley & Belfus, Philadelphia, Pa.
5. Fillastre, J. P., A. Leroy, G. Humbert, B. Moulin, P. Bernadet, and S. Josse. 1987. Pharmacokinetics of habekacin in patients with renal insufficiency. Antimicrob. Agents Chemother. 31:575-577.
6. Gilbert, D. N. 1991. Once-daily aminoglycoside therapy. Antimicrob. Agents Chemother. 35:399-405.
7. Gilbert, D. N., and W. M. Benett. 1989. Use of antimicrobial agents inrenal failure. Infect. Dis. Clin. N. Am. 3:517-531.
8. Hamilton-Miller, J. M., and S. Shah. 1995. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 35:865-868.
9. Hayashi, I., M. Inoue, and H. Hashimoto. 1994. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drugs Exp. Clin. Res. 20:225-232.
10. Kaupusnik, J. E., and M. A. Sande. 1986. Novel approaches for the use of aminoglycosides: the value of experimental models. J. Antimicrob. Chemother. 17(Suppl. A):7-10.
11. Kondoh, S., K. Iimura, H. Yamamoto, K. Maeda, and H. Umezawa. 1973. Syntheses of (S)-4 amino-2-hydroxy-butyryl derivatives of 3′,4′-dideoxykanamycin B and their antibacterial activities. J. Antibiot. 26:705-707.
12. Michaels, A. S. 1966. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans. Am. Soc. Artif. Intern. Organs 12:387-392.
13. Sakai, K., and M. Mineshima. 1984. Performance evaluation of a module in artificial kidney system. J. Chem. Eng. Jpn. 17:198-203.
14. Yourassowsky, E., M. P. Van der Linden, and F. Crokaert. 1990. One shot of high dose amikacin: a working hypothesis. Chemotherapy (Basel) 36:1-7.